Commonest malignancy of the female genital tract in North America, accounting for 13% of all female cancers. It often presents early due to women's propensity to investigate abnormal bleeding.
Endometrial cancer is the number one cancer caused by obesity due to aromatase andostrione from the adrenals to unapposed estrone. (CONFIRM THIS).
50 lbs is a 10x icreased risk
other risk factors include:
factors that decrease risk include:
Per vaginal bleeding in pre-meas
Postmenopausal bleeding is cancer until proven otherwise.
Pap tests have a low sensitivty (~50%); endometrial biopsy is indicated.
D and C
aspiration biopsy: sensitivity ~90%
hysteroscopic biopsy
Ultasound can be done to assess endometrial thickness.
Various subtypes include:
endometroid: adenocarcinoma (+/- squamoid elements)
clear cell
uterine papillary serous
Vaginal surgery and laparoscopy are options, with or without lympadenectomy.
Radiation and chemotherapy also important options.
Survival depends on stage, rangin from ~75% for stage I and ~10% for stage IV.